These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effect of C1q-binding donor-specific anti-HLA antibodies on the clinical outcomes of patients after renal transplantation: A systematic review and meta-analysis. Kang ZY; Liu C; Liu W; Li DH Transpl Immunol; 2022 Jun; 72():101566. PubMed ID: 35257893 [TBL] [Abstract][Full Text] [Related]
5. Evidence for an important role of both complement-binding and noncomplement-binding donor-specific antibodies in renal transplantation. Viglietti D; Lefaucheur C; Glotz D Curr Opin Organ Transplant; 2016 Aug; 21(4):433-40. PubMed ID: 27348472 [TBL] [Abstract][Full Text] [Related]
6. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis. Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738 [TBL] [Abstract][Full Text] [Related]
7. Clinical and immunological relevance of antibodies in solid organ transplantation. Mehra NK; Baranwal AK Int J Immunogenet; 2016 Dec; 43(6):351-368. PubMed ID: 27870356 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience. Olszowska-Zaremba N; Gozdowska J; Zagożdżon R Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613 [TBL] [Abstract][Full Text] [Related]
12. Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients. Lefaucheur C; Viglietti D; Bouatou Y; Philippe A; Pievani D; Aubert O; Duong Van Huyen JP; Taupin JL; Glotz D; Legendre C; Loupy A; Halloran PF; Dragun D Kidney Int; 2019 Jul; 96(1):189-201. PubMed ID: 31005275 [TBL] [Abstract][Full Text] [Related]
13. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction. Iasella CJ; Ensor CR; Marrari M; Mangiola M; Xu Q; Nolley E; Moore CA; Morrell MR; Pilewski JM; Sanchez PG; McDyer JF; Zeevi A J Heart Lung Transplant; 2020 Dec; 39(12):1417-1425. PubMed ID: 32981841 [TBL] [Abstract][Full Text] [Related]
14. Donor-Specific HLA Antibodies: A Review of Data Published in 2016. Idica A; Everly MJ Clin Transpl; 2016; 32():13-22. PubMed ID: 28564519 [TBL] [Abstract][Full Text] [Related]
15. Complement-binding anti-HLA antibodies are independent predictors of response to treatment in kidney recipients with antibody-mediated rejection. Viglietti D; Bouatou Y; Kheav VD; Aubert O; Suberbielle-Boissel C; Glotz D; Legendre C; Taupin JL; Zeevi A; Loupy A; Lefaucheur C Kidney Int; 2018 Oct; 94(4):773-787. PubMed ID: 29801667 [TBL] [Abstract][Full Text] [Related]
16. Anti-human leukocyte antigen immunization after early allograft nephrectomy. Del Bello A; Congy N; Sallusto F; Cardeau-Desangles I; Fort M; Esposito L; Guitard J; Cointault O; Lavayssière L; Nogier MB; Game X; Blancher A; Rostaing L; Kamar N Transplantation; 2012 May; 93(9):936-41. PubMed ID: 22361471 [TBL] [Abstract][Full Text] [Related]
17. A diagnostic 'C' saw: the ups and downs of C1q testing. Gebel HM; Bray RA Curr Opin Organ Transplant; 2019 Aug; 24(4):402-410. PubMed ID: 31135562 [TBL] [Abstract][Full Text] [Related]
18. Pre-transplant donor HLA-specific antibodies: characteristics causing detrimental effects on survival after lung transplantation. Smith JD; Ibrahim MW; Newell H; Danskine AJ; Soresi S; Burke MM; Rose ML; Carby M J Heart Lung Transplant; 2014 Oct; 33(10):1074-82. PubMed ID: 24954882 [TBL] [Abstract][Full Text] [Related]